Brief: Agilon Health Q1 Revenue USD 1,530 Million Vs. IBES Estimate USD 1,504 Million
May 06 (Reuters) - Agilon Health Q1 adjusted EBITDA USD 21 million vs. IBES estimate USD 15.9 million. Q1 net income USD 12 million vs. IBES estimate USD -3.01 million
Recent news on Agilon Health
See all newsU.S. RESEARCH ROUNDUP-Costco Wholesale, HCA Healthcare, Micron Technology
U.S. RESEARCH ROUNDUP- Applied Materials, NVIDIA, Thermo Fisher Scientific
U.S. RESEARCH ROUNDUP-Airbnb, HII, Tesla
U.S. STOCKS ON THE MOVE-Krispy Kreme, Tesla, Axon Enterprise
U.S. STOCKS ON THE MOVE-Albemarle, Howmet, Travere Therapeutics